SCHEMBL14928666

SCHEMBL14928666

C[C@H](CN)c1ccccn1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 1/20 0.48
▸ TAAR1 Q96RJ0 2/20 0.48
▸ KCNA5 P22460 6/20 0.46
▸ KCNH2 Q12809 1/20 0.46
▸ SLC6A2 P23975 2/20 0.45
▸ SLC6A4 P31645 2/20 0.45
▸ SLC6A3 Q01959 1/20 0.45
▸ KCNE1 P15382 2/20 0.43
▸ CYP2D6 P10635 1/20 0.43
▸ CYP1A2 P05177 2/20 0.42
▸ CHRM2 P08172 1/20 0.42
▸ SCN1A P35498 1/20 0.42
▸ SCN2A Q99250 1/20 0.42
▸ SCN3A Q9NY46 1/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.41
▸ HRH1 P35367 1/20 0.41
▸ CXCR4 P61073 3/20 0.40
▸ LOXL2 Q9Y4K0 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL701235 1.00 TSHR (0.48) TSHRTAAR1KCNA5KCNH2SLC6A2
SCHEMBL30498939 1.00 TSHR (0.48) TSHRTAAR1KCNA5KCNH2SLC6A2
SCHEMBL19101954 0.82 TSHR (0.47) TSHRTAAR1KCNA5KCNH2SLC6A2
SCHEMBL10247782 0.81 KCNA5 (0.52) TSHRKCNA5KCNH2SLC6A2SLC6A4
SCHEMBL817770 0.81 KCNA5 (0.52) TSHRKCNA5KCNH2SLC6A2SLC6A4
SCHEMBL13862942 0.81 KCNA5 (0.52) TSHRKCNA5KCNH2SLC6A2SLC6A4
SCHEMBL13638230 0.81 KCNA5 (0.52) TSHRKCNA5KCNH2SLC6A2SLC6A4
SCHEMBL7914310 0.80 TAAR1 (0.52) TSHRTAAR1KCNA5KCNH2SLC6A2
SCHEMBL22275776 0.80 CXCR4 (0.48) TSHRKCNA5KCNH2SLC6A2SLC6A4
SCHEMBL23689568 0.79 TSHR (0.48) TSHRKCNA5KCNH2SLC6A2SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895585-B2 Nicotinamide derivative or salt thereof FUJIFILM CORPORATION (JP) 2014-11-25 — — US disclosed
US-8809371-B2 — — 2014-08-19 — — US disclosed
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2013-05-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF SYK, CD38, BTK TSHR 1886/4885TAAR1 693/4885KCNA5 1452/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback